Siemens Healthineers signs agreement with Alibaba DAMO Academy to accelerate the popularization of AI 'one-scan multi-screen' technology

Siemens Healthineers signs an agreement with Alibaba DAMO Academy, planning to combine DAMO Academy's newly developed 'One-Scan Multi-Screen' AI technology with Siemens Healthineers' imaging equipment and clinical applications to assist in the early detection of major diseases such as cancer and cardiovascular diseases. DAMO Academy's self-developed 'One-Scan Multi-Screen' technology based on plain scan CT + AI has successively broken through major international medical challenges such as digestive tumor imaging screening and aortic dissection warning, and has been recognized by the U.S. FDA as a 'Breakthrough Medical Device'. The two parties plan to promote the use of a single CT scan to detect multiple high-lethality cancers and cardiovascular critical emergencies with the help of Siemens Healthineers' resources.